ID: ALA5277752

Max Phase: Preclinical

Molecular Formula: C25H22N2O7

Molecular Weight: 462.46

Associated Items:

Representations

Canonical SMILES:  CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c(/C=C(\C)C(=O)OC)c(O)ccc3nc2-1

Standard InChI:  InChI=1S/C25H22N2O7/c1-4-25(32)17-9-19-21-13(10-27(19)22(29)16(17)11-34-24(25)31)8-14-15(7-12(2)23(30)33-3)20(28)6-5-18(14)26-21/h5-9,28,32H,4,10-11H2,1-3H3/b12-7+/t25-/m0/s1

Standard InChI Key:  RFDLOZLLRJVPSF-FRHHVXPKSA-N

Associated Targets(Human)

HCT-8 3484 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

SGC-7901 2773 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HepG2 196354 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

KB 17409 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 462.46Molecular Weight (Monoisotopic): 462.1427AlogP: 2.36#Rotatable Bonds: 3
Polar Surface Area: 127.95Molecular Species: NEUTRALHBA: 9HBD: 2
#RO5 Violations: 0HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 8.89CX Basic pKa: 3.10CX LogP: 1.85CX LogD: 1.84
Aromatic Rings: 3Heavy Atoms: 34QED Weighted: 0.35Np Likeness Score: 1.26

References

1. Khaiwa N, Maarouf NR, Darwish MH, Alhamad DWM, Sebastian A, Hamad M, Omar HA, Orive G, Al-Tel TH..  (2021)  Camptothecin's journey from discovery to WHO Essential Medicine: Fifty years of promise.,  223  [PMID:34175539] [10.1016/j.ejmech.2021.113639]

Source